Errate: Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I-III: A Systematic Review and Network Meta-Analysis.

Ao, Mengyin; Ding, Ting; Tang, Dan; Xi, Mingrong

Ao, Mengyin; Ding, Ting; Tang, Dan; Xi, Mingrong.

Afiliação

Ao M; Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China (mainland).
Ding T; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Chengdu, Sichuan, China (mainland).
Tang D; Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China (mainland).
Xi M; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Chengdu, Sichuan, China (mainland).

Med Sci Monit ; 28: e937457, 2022 Jun 08.

Article em En | MEDLINE | ID: mdl-35673972

Assuntos

Neoplasias do Endométrio; Neoplasias do Endométrio/patologia; Neoplasias do Endométrio/terapia; Endométrio/patologia; Feminino; Humanos; Estadiamento de Neoplasias; Metanálise em Rede; Radioterapia Adjuvante

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio Tipo de estudo: Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google